1,347
Views
19
CrossRef citations to date
0
Altmetric
Article

Sirtuin 1 regulates matrix metalloproteinase-13 expression induced by Porphyromonas endodontalis lipopolysaccharide via targeting nuclear factor–κB in osteoblasts

, , , , , & show all
Article: 1317578 | Received 20 Dec 2016, Accepted 05 Apr 2017, Published online: 21 Apr 2017

References

  • Uusitalo H, Hiltunen A, Söderström M, et al. Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus. Calcif Tissue Int. 2000;67:1–9.
  • Lenglet S, Mach F, Montecucco F. Role of matrix metalloproteinase-8 in atherosclerosis. Mediators Inflamm. 2013;2013:659282.
  • Tardif G, Reboul P, Pelletier J-P, et al. Ten years in the life of an enzyme: the story of the human MMP-13 (collagenase-3). Mod Rheumatol. 2004;14:197–204.
  • Vandenbroucke RE, Dejonckheere E, Van Hauwermeiren F, et al. Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF. EMBO Mol Med. 2013;5:932–948.
  • Wahlgren J, Maisi P, Sorsa T, et al. Expression and induction of collagenases (MMP-8 and −13) in plasma cells associated with bone-destructive lesions. J Pathol. 2001;194:217–224.
  • Stickens D, Behonick DJ, Ortega N, et al. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development. 2004;131:5883–5895.
  • De Aquino SG, Guimaraes MR, Stach-Machado DR, et al. Differential regulation of MMP-13 expression in two models of experimentally induced periodontal disease in rats. Arch Oral Biol. 2009;54:609–617.
  • Bhalla G, Astekar MS, Ramesh G, et al. Collagenase-3 expression in periapical lesions: an immunohistochemical study. Biotech Histochem. 2014;89:457–463.
  • Matsui H, Yamasaki M, Nakata K, et al. Expression of MMP-8 and MMP-13 in the development of periradicular lesions. Int Endod J. 2011;44:739–745.
  • Leonardi R, Caltabiano R, Loreto C. Collagenase-3 (MMP-13) is expressed in periapical lesions: an immunohistochemical study. Int Endod J. 2005;38:297–301.
  • Andonovska B, Dimova C, Panov S. Matrix metalloproteinases (MMP-1, −8, −13) in chronic periapical lesions. Vojnosanit Pregl. 2008;65:882–886.
  • Tomazinho LF, Avila-Campos MJ. Detection of Porphyromonas gingivalis, Porphyromonas endodontalis, Prevotella intermedia, and Prevotella nigrescens in chronic endodontic infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:285–288.
  • Murakami Y, Hanazawa S, Tanaka S, et al. A possible mechanism of maxillofacial abscess formation: involvement of Porphyromonas endodontalis lipopolysaccharide via the expression of inflammatory cytokines. Oral Microbiol Immunol. 2001;16:321–325.
  • Guo J, Yang D, Okamura H, et al. Calcium hydroxide suppresses Porphyromonas endodontalis lipopolysaccharide-induced bone destruction. J Dent Res. 2014;93:508–513.
  • Yang D, Li R, Qiu LH, et al. Effects of lipopolysaccharides extracted from Porphyromonas endodontalis on the expression of IL-1beta mRNA and IL-6 mRNA in osteoblasts. Shanghai Kou Qiang Yi Xue. 2009;18:194–197.
  • Yu Y, Qiu L, Guo J, et al. Effect of lipopolysaccharides from Porphyromonas endodontalis on the expression of macrophage colony stimulating factor in mouse osteoblasts. Zhonghua Kou Qiang Yi Xue Za Zhi. 2014;49:535–539.
  • Yu Y, Qiu L, Guo J, et al. TRIB3 mediates the expression of Wnt5a and activation of nuclear factor-kappaB in Porphyromonas endodontalis lipopolysaccharide-treated osteoblasts. Mol Oral Microbiol. 2015;30:295–306.
  • Edwards JR, Perrien DS, Fleming N, et al. Silent information regulator (Sir)T1 inhibits NF-κB signaling to maintain normal skeletal remodeling. J Bone Miner Res. 2013;28:960–969.
  • Zhang QB, Cao W, Liu YR, et al. Effects of Sirtuin 1 on the proliferation and osteoblastic differentiation of periodontal ligament stem cells and stem cells from apical papilla. Genet Mol Res. 2016;15:gmr.15015234.
  • Herranz D, Munoz-Martin M, Canamero M, et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun. 2010;1:3.
  • Lee S-I, Min K-S, Bae W-J, et al. Role of SIRT1 in heat stress- and lipopolysaccharide-induced immune and defense gene expression in human dental pulp cells. J Endod. 2011;37:1525–1530.
  • Singh NP, Singh UP, Hegde VL, et al. Resveratrol (trans-3,5,4ʹ-trihydroxystilbene) suppresses EL4 tumor growth by induction of apoptosis involving reciprocal regulation of SIRT1 and NF-kappaB. Mol Nutr Food Res. 2011;55:1207–1218.
  • Shen Z, Ajmo JM, Rogers CQ, et al. Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1047–G1053.
  • Lee J-H, Song M-Y, Song E-K, et al. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes. 2009;58:344–351.
  • Luo J, Nikolaev AY, Imai S, et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 2001;107:137–148.
  • Jeong YJ, Shin JM, Bae YS, et al. Melittin has a chondroprotective effect by inhibiting MMP-1 and MMP-8 expressions via blocking NF-kappaB and AP-1 signaling pathway in chondrocytes. Int Immunopharmacol. 2015;25:400–405.
  • Zheng C, Yin Q, Wu H. Structural studies of NF-κB signaling. Cell Res. 2011;21:183–195.
  • Ghizzoni M, Haisma HJ, Maarsingh H, et al. Histone acetyltransferases are crucial regulators in NF-κB mediated inflammation. Drug Discov Today. 2011;16:504–511.
  • Kiernan R, Bres V, Ng RW, et al. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem. 2003;278:2758–2766.
  • Chen L, Fischle W, Verdin E, et al. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science. 2001;293:1653–1657.
  • Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J. 2004;23:2369–2380.
  • Koga T, Nishihara T, Fujiwara T, et al. Biochemical and immunobiological properties of lipopolysaccharide (LPS) from Bacteroides gingivalis and comparison with LPS from Escherichia coli. Infect Immun. 1985;47:638–647.
  • Roberts HC, Moseley R, Sloan AJ, et al. Lipopolysaccharide alters decorin and biglycan synthesis in rat alveolar bone osteoblasts: consequences for bone repair during periodontal disease. Eur J Oral Sci. 2008;116:207–216.
  • Gao A, Kantarci A, Herrera BS, et al. A critical role for suppressors of cytokine signaling 3 in regulating LPS-induced transcriptional activation of matrix metalloproteinase-13 in osteoblasts. PeerJ. 2013;1:e51.
  • Hess J, Porte D, Munz C, et al. AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J Biol Chem. 2001;276:20029–20038.
  • Wu G, Wang L, Li H, et al. Function of sustained released resveratrol on IL-1beta-induced hBMSC MMP13 secretion inhibition and chondrogenic differentiation promotion. J Biomater Appl. 2016;30:930–939.
  • Lin TH, Tang CH, Wu K, et al. 15-deoxy-Delta(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-alpha-induced matrix metalloproteinase 13 production via the antagonism of NF-kappaB activation in human synovial fibroblasts. J Cell Physiol. 2011;226:3242–3250.
  • Pan W, Yu H, Huang S, et al. Resveratrol protects against TNF-α-induced injury in human umbilical endothelial cells through promoting Sirtuin-1-induced repression of NF-KB and p38 MAPK. Plos One. 2016;11:e0147034.
  • Li W, Cai L, Zhang Y, et al. Intra-articular resveratrol injection prevents osteoarthritis progression in a mouse model by activating SIRT1 and thereby silencing HIF-2α. J Orthop Res. 2015;33:1061–1070.
  • Hong C-Y, Lin S-K, Kok S-H, et al. The role of lipopolysaccharide in infectious bone resorption of periapical lesion. J Oral Pathol Med. 2004;33:162–169.
  • Wilson M, Reddi K, Henderson B. Cytokine-inducing components of periodontopathogenic bacteria. J Periodontal Res. 1996;31:393–407.
  • Huang W, Shang WL, Wang HD, et al. Sirt1 overexpression protects murine osteoblasts against TNF-alpha-induced injury in vitro by suppressing the NF-kappaB signaling pathway. Acta Pharmacol Sin. 2012;33:668–674.
  • Yu YQ, Guo JJ, Qiu LH, et al. Effect of NF-kappaB on the expression of interleukin-6 induced by lipopolysaccharides of Porphyromonas endodontalis in MC3T3-E1 cells. Shanghai Kou Qiang Yi Xue. 2013;22:378–383.
  • Tzeng H-E, Chen J-C, Tsai C-H, et al. CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin-dependent pathway. J Cell Physiol. 2011;226:3181–3189.
  • Imagawa K, De Andrés MC, Hashimoto K, et al. The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes–implications for osteoarthritis. Biochem Biophys Res Commun. 2011;405:362–367.
  • Fei Y, Shimizu E, McBurney MW, et al. Sirtuin 1 is a negative regulator of parathyroid hormone stimulation of matrix metalloproteinase 13 expression in osteoblastic cells: role of sirtuin 1 in the action of PTH on osteoblasts. J Biol Chem. 2015;290:8373–8382.